checkAd

     567  0 Kommentare Pulmonary/Respiratory Drug Delivery Market Worth 52.37 Billion USD by 2021

    PUNE, India, February 20, 2017 /PRNewswire/ --

    According to a new market research report "Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021" published by MarketsandMarkets, The market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period.

         (Logo: http://photos.prnewswire.com/prnh/20160303/792302 )

    Browse 104 market data Tables and 33 Figures spread through 150 Pages and in-depth TOC on "Pulmonary/ Respiratory Drug Delivery Market"

    http://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug-delivery-market-179682410.html

    Early buyers will receive 10% customization on this report. 

    Growth in this Pulmonary Drug Delivery Market is mainly driven by increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. Emerging markets such as India, China, & Japan and growth in online marketing channels are expected to offer lucrative growth opportunities for market players in the coming years. On the other hand, factors such as regulatory issues and pricing pressures are the major factors restraining market growth.

    The Pulmonary Drug Delivery Market is segmented based on formulations, canister type, applications, end users, and regions. On the basis of end user, the market is segmented into hospitals & clinics and homecare settings. The hospitals & clinics segment dominated the market in 2016, this is attributed to the increasing incidence of diseases such as pneumonia and acute exacerbation of COPD (AECOPD) is driving the number of hospitalizations each year.

    Inquiry Details: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=179682410

    Based on canister type, the market is segmented into plain and coated canister. The coated canister segment is expected to be the fastest growing market in canister type segments in the market during the forecast period. This is attributed to advantages such as robust profile for filling, avoiding crimping, and withstanding the pressure associated with the type of propellant (HFAs or CFCs).

    Seite 1 von 3


    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Pulmonary/Respiratory Drug Delivery Market Worth 52.37 Billion USD by 2021 PUNE, India, February 20, 2017 /PRNewswire/ - According to a new market research report "Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), …